Page 3 - Spectrum Volume 14 Issue 3
P. 3

2020 | Spectrum | Volume 14 Number 3   3

        Prof Ashutosh Sharma on


        Convergence of multiple

        disciplines to address

        future challenges




        STAFF WRITTER             which as a result of sustainable
                                  knowledge, can address major
         SRM University-AP, Andhra  challenges.” Urging everyone
        Pradesh invited Prof Ashutosh  to do their individual job well,
        Sharma, Secretary, Department of  Prof Sharma informed that
        Science and Technology (DST),  capacity of learning is the most
        Government of India to deliver  prized possession. He said,
        the University Distinguished  “Capacity to adapt to change,
        Lecture. Prof K Hema Chandra  learn new things, and lifelong
        Reddy, Chairman, Andhra  learning is paramount to thrive.
        Pradesh State Council Of Higher  The convergence of multiple
        Education, Prof V S Rao, Vice-  disciplines has an instrumental
        Chancellor, Prof D Narayana  role in solving crucial problems.
        Rao, Pro Vice-Chancellor, faculty  Our education system must
        members, and more than 700  have parallel structures for   SRM hospital launches
        participants attended the lecture  multidisciplinary knowledge
        on “Art of Science in the Time  creation and research. We should
        of Virus and Beyond: The Brave  be crossing borders of knowledge   third phase f COVAXIN
        New World”. For the first time,  and expanding the boundaries
        SRM AP presented welcome  of disciplines.”
        bouquet and virtual memento   Prof Sharma suggested the   trial; Seeks volunteers
        to Prof. Ashutosh Sharma. The   scientific community to become
        virtual avatars were created by   self-reliant. He said, “Quality,
        SRM AP students who used   relevance, and appropriate
        applications developed by them   direction of knowledge will   STAFF WRITTER  Investigator for COVAXIN Dr.  the human volunteer,” said Dr.Lt
        such as character creator and   lead the world. Coupled with                  Satyajit Mahopatra along with  Col Dr. A. Ravi Kumar, Pro
        bundle software. Further, Prof   it, cultural aspects such as   “SRM Medical College  Dr. Melvin George.  Vice Chancellor (Medical and
        D Narayana Rao extended the   self-confidence, and self-  Hospital and Research Centre                  Health Sciences).
        warmest welcome to the guests   respect makes up the art of   (SRM MCHRC), Kattankulathur   “Any person above 18 years
        and commenced the programme.   science.” Emphasizing on the   has successfully completed   of age and had not suffered   Indian Council for Medical
        He informed, “DST has taken   importance of collaboration, Prof   two phases of human testing   COVID19 illness in the past  Research (ICMR) is collaborating
        up the daunting task of making   Sharma concluded, “Covid 19   of the COVAXIN trial and the   can participate as a volunteer  with Bharat Biotech, Hyderabad
        India as one of the world leaders   spontaneously spurred the spirit   third phase for the same will   in this trial. Pregnant women  in the development of COVAXIN.
        in science and technology   of collaboration with a clear and   start today (7th December   are excluded. The vaccine shot  SRM Medical College Hospital
        with several projects aimed   shared purpose. Researchers   2020), said SRM MCHRC’s   will be administered twice -  and Research Centre is the
        at motivating and harnessing   should have a scientific temper   Pro Chancellor (Academics)   28 days apart,” said Principal  only private Medical College
        talent to be better equipped to   which entails rational analysis of   Dr. P. Sathyanarayanan.   Investigator for COVAXIN, Dr.  Hospital in Tamil Nadu to be
        face future challenges”.                                                      Satyajit Mahopatra.       selected to carry out all three
                                  situation, positivity, optimism,   Speaking at a press meet                   phases of the COVAXIN trial.
         Hema Chandra Reddy  and cooperation. The scientific   held at the launch of the third   The hospital will be able to   This vaccine has got the nod
        delivered a brief speech on  community should critically   phase of the COVAXIN trial   conduct the trial for 50 people   for human trials from the Drug
        research initiatives in science  challenge views, be inquisitive,   in the hospital, he said that the   a day. Once the process is   Controller General of India.
        and technology introduced by the  and be able to engage people   number of patients who will be   successful, the vaccine will be
        Government of Andhra Pradesh.  in purposeful conversation.”   tested in this final phase will be   approved on a fast track basis.   “SRM MCHRC is well-
        He informed, “Government of   Prof Ashuthosh Sharma said   over 1000.         SRM MCHRC is currently    equipped with various facilities
        AP is planning to establish AP   “the scientists of the country               treating 21 COVID 19 patients   to handle clinical trials such as
        state research board to promote   need to be leaders and not the   “Until now we have received   and on average 80 people are   COVID 19. It provides 24-hours
        multidisciplinary quality research   followers.     500 volunteers for the test. We   screened for COVID19.  emergency services and has well-
        and coordination among the                          will be taking in more volunteers   The first phase of human   qualified doctors and nurses,” said
        universities.” Further, Prof   Some of the faculty members   till the end of December 2020.   trials at SRM MCHRC began   Dr. A. Sundaram, Dean, SRM
        Ashutosh Sharma took the virtual  of SRM University-AP interacted   We are trying our best to make   in July 2020 with 30 volunteers.   MCHRC
        podium to speak about science,  with the DST Secretary and   this work, as it will be India’s   The second phase was done in   The hospital has so far treated
        technology, and innovation.  made a brief presentation   first indigenous vaccine,” he   August in which 45 volunteers   1400 COVID patients since April
        Picturesquely, he explained,  about a few flagship projects   added.          participated. In both these phases,   2020. Both Allopathy and Siddha
        “Innovation pertains to visual  of the University viz., “SRM –   Also present with SRM   the safety of the vaccine was   medicines in combination are used
        imaginations and thinking.  Amara Raja Centre for Energy   MCHRC’s Pro Chancellor   ascertained. In the trial conducted   to treat COVID patients. SRM
        Knowledge becomes sustainable  Storage Devices”, “Hydrogen-  (Academics) Dr. P. Sathya   at SRM hospital, none of the   Medical College Hospital and
        when invention and innovation  Powered Fuel Cell Based Train   narayanan were Pro Vice   volunteers suffered any serious   Research Centre has been doing
        are balanced. Invention uses  in association with the Ministry   Chancellor (Medical and Health   reactions except for mild fever   this under the able guidance of
        resources to produce knowledge,  of Railways”, “3-D printing of   Sciences) Dr. Lt Col Dr. A. Ravi   and body ache.  Chancellor Dr. T.R. Paarivendhar
        whereas innovation deploys  Gold Jewellery in association   Kumar, Dean  Dr. A. Sundaram,               and Pro Chancellor (Academics)
        knowledge to generate economic  with Tanishq Jewellers”. Prof   Medical  Superintendent   “SRM MCHRC is the only  Dr. P. Sathyanarayanan. Those
        resources”.               Ashthosh Sharma commended the   Dr. K. Thangaraj, Deputy  private Medical College Hospital  wishing to volunteer for this
                                  outstanding research initiatives   Medical Superintendent  Dr.  in Tamil Nadu to undertake this  clinical trial can call 7598951868,
         Prof Sharma accentuated that
        Covid-19 taught us the lesson   of the University and said that   R. Balamurugan, Director  trial. The third phase is to assess  7358026002, 044-47432341 or
                                  DST will be happy to extend
                                                            (Communication) Mr. R.  the efficacy of the Vaccine in  email to srm.covaxin2020@
        that “sustainable development,
                                  the support.              Nandakummar and Principal  inducing immunogenicity in  gmail.com.
   1   2   3   4   5   6   7   8